Yan Li to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications Yan Li has written about Angiotensin II Type 1 Receptor Blockers.
Connection Strength
1.072
-
Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int. 2010 Jun; 77(11):1000-9.
Score: 0.349
-
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol. 2009 Sep; 297(3):F791-801.
Score: 0.333
-
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A. 2008 Oct 14; 105(41):15896-901.
Score: 0.317
-
Inhibition of renin: an updated review of the development of renin inhibitors. Curr Opin Investig Drugs. 2007 Sep; 8(9):750-7.
Score: 0.073